Acute Respiratory Distress Syndrome Treatment Device Market

The global Acute Respiratory Distress Syndrome Treatment Device market was valued at US$ 388.6 million in 2022 and is projected to reach US$ 476.9 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks? gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
Acute Respiratory Distress Syndrome Treatment Device Market aims to provide a comprehensive presentation of the global market for Acute Respiratory Distress Syndrome Treatment Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Respiratory Distress Syndrome Treatment Device. Acute Respiratory Distress Syndrome Treatment Device Market contains market size and forecasts of Acute Respiratory Distress Syndrome Treatment Device in global, including the following market information:

• Global Acute Respiratory Distress Syndrome Treatment Device Market Revenue, 2018-2023, 2024-2029, ($ millions)
• Global Acute Respiratory Distress Syndrome Treatment Device Market Sales, 2018-2023, 2024-2029, (K Units)
• Global top five Acute Respiratory Distress Syndrome Treatment Device companies in 2022 (%)

North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.
We surveyed the Acute Respiratory Distress Syndrome Treatment Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Respiratory Distress Syndrome Treatment Device Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acute Respiratory Distress Syndrome Treatment Device Market Segment Percentages, by Type, 2022 (%)

• Mobile Devices
• Fixed Devices

Global Acute Respiratory Distress Syndrome Treatment Device Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acute Respiratory Distress Syndrome Treatment Device Market Segment Percentages, by Application, 2022 (%)

• General Hospitals
• Specialty Clinics

Global Acute Respiratory Distress Syndrome Treatment Device Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acute Respiratory Distress Syndrome Treatment Device Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa
• Competitor Analysis
• The report also provides analysis of leading market participants including:
• Key companies Acute Respiratory Distress Syndrome Treatment Device revenues in global market, 2018-2023 (Estimated), ($ millions)
• Key companies Acute Respiratory Distress Syndrome Treatment Device revenues share in global market, 2022 (%)
• Key companies Acute Respiratory Distress Syndrome Treatment Device sales in global market, 2018-2023 (Estimated), (K Units)
• Key companies Acute Respiratory Distress Syndrome Treatment Device sales share in global market, 2022 (%)
• Further, the report presents profiles of competitors in the market, key players include:
• Athersys
• Beurer
• BioMarck Pharmaceuticals
• BPL Medical Technologies
• Faron Pharmaceuticals
• GE Healthcare
• Hamilton Medical
• Masimo
• Nonin Medical
• Phillips
• ResMed
• Smiths Medical

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Acute Respiratory Distress Syndrome Treatment Device, market overview.
• Chapter 2: Global Acute Respiratory Distress Syndrome Treatment Device market size in revenue and volume.
• Chapter 3: Detailed analysis of Acute Respiratory Distress Syndrome Treatment Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Acute Respiratory Distress Syndrome Treatment Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Acute Respiratory Distress Syndrome Treatment Device capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.